Related topics: cancer , cancer cells , patients , tumor , smokers
Lung cancer
hideLung cancer is a disease of uncontrolled cell growth in tissues of the lung. This growth may lead to metastasis, which is the invasion of adjacent tissue and infiltration beyond the lungs. The vast majority of primary lung cancers are carcinomas of the lung, derived from epithelial cells. Lung cancer, the most common cause of cancer-related death in men and the second most common in women (after breast cancer), is responsible for 1.3 million deaths worldwide annually. The most common symptoms are shortness of breath, coughing (including coughing up blood), and weight loss.
The main types of lung cancer are small cell lung carcinoma and non-small cell lung carcinoma. This distinction is important, because the treatment varies; non-small cell lung carcinoma (NSCLC) is sometimes treated with surgery, while small cell lung carcinoma (SCLC) usually responds better to chemotherapy and radiation. The most common cause of lung cancer is long-term exposure to tobacco smoke. The occurrence of lung cancer in nonsmokers, who account for as many as 15% of cases , is often attributed to a combination of genetic factors, radon gas, asbestos, and air pollution, including secondhand smoke.
Lung cancer may be seen on chest radiograph and computed tomography (CT scan). The diagnosis is confirmed with a biopsy. This is usually performed via bronchoscopy or CT-guided biopsy. Treatment and prognosis depend upon the histological type of cancer, the stage (degree of spread), and the patient's performance status. Possible treatments include surgery, chemotherapy, and radiotherapy. With treatment, the five-year survival rate is 14%.
For more information about Lung cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with lung cancer
Research yields new agent for some drug-resistant non-small cell lung cancers
Dec 23, 2009 |
5 / 5 (1) |
0
The ability to make, test, and map the atomic structure of new anti-cancer agents has enabled a team of Dana-Farber Cancer Institute scientists to discover a compound capable of halting a common type of drug-resistant ...
Adverse consequences of obesity may be greater than previously thought
Dec 23, 2009 |
4.3 / 5 (7) |
1
The link between obesity and cardiovascular mortality may be substantially underestimated, while some of the adverse consequences of being underweight may be overstated, concludes a study published in the British Medical ...
Search results for lung cancer
Scientists take important step toward the proverbial fountain of youth
Dec 22, 2009 |
4.7 / 5 (6) |
0
Going back for a second dessert after your holiday meal might not be the best strategy for living a long, cancer-free life say researchers from the University of Alabama at Birmingham. That's because they've shown exactly ...
Protein inhibits cancer cell growth
Dec 21, 2009 |
5 / 5 (2) |
0
(PhysOrg.com) -- Researchers at the University of Toronto and Goethe University in Germany have discovered a protein that can inhibit the growth of cancer cells, providing crucial clues for the future development of new drugs ...
Researchers find new patterns in H1N1 deaths
Dec 23, 2009 |
5 / 5 (4) |
1
Brazilian researchers have performed the first-ever autopsy study to examine the precise causes of death in victims of the H1N1 swine flu.
Chicago Cancer Genome Project studies genetics of 1,000 tumors
Dec 22, 2009 |
5 / 5 (2) |
0
No two tumors are alike, but analyzing the genetics of cancers from different parts of the body may reveal surprising details useful for treatment and prevention.
Protein that represses genes may play role in cell growth
Dec 21, 2009 |
not rated yet |
0
(PhysOrg.com) -- A Cornell study shows the protein not only activates some genes involved in the regulation of cell growth and signaling, but also may play a role in preventing cancers by inhibiting cell proliferation.
Drug for Multiple Myeloma Demonstrated to Significantly Extend Disease-Free Survival
Dec 21, 2009 |
5 / 5 (1) |
0
(PhysOrg.com) -- Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also ...
List of search results for lung cancer
